Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 61,738	$ 86,952
Accounts receivable, net	47,709	47,682
Inventories	26,457	12,158
Prepaid expenses	4,792	3,349
Other current assets	4,274	1,201
Total current assets	144,970	151,342
Property and equipment, net	3,653	3,222
Operating lease right-of-use assets	7,827	7,185
Intangible assets, net	49,347	48,754
Goodwill	21,208	21,208
Other assets	1,798	858
Total assets	228,803	232,569
Current liabilities
Accounts payable	23,312	9,236
Accrued expenses	27,949	40,791
Current portion of operating lease liabilities	2,392	1,718
Current portion of contingent royalty obligation payable to Evolus Founders	10,097	11,215
Total current liabilities	63,750	62,960
Long-term portion of operating lease liabilities	7,039	6,755
Long-term portion of contingent royalty obligation payable to Evolus Founders	28,489	33,550
Long-term portion of term loan, net of discount and issuance costs	145,475	121,506
Contingent milestone payment	2,681	2,270
Deferred tax liability	21	6
Total liabilities	247,455	227,047
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit)
Preferred stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	0	0
Common stock, $0.00001 par value; 100,000,000 shares authorized; 64,638,978 and 63,497,548 shares issued and outstanding as of June 30, 2025 and December 31, 2024, respectively	1	1
Additional paid-in capital	627,379	615,825
Accumulated other comprehensive loss	(599)	(905)
Accumulated deficit	(645,433)	(609,399)
Total stockholders’ equity (deficit)	(18,652)	5,522
Total liabilities and stockholders’ equity (deficit)	$ 228,803	$ 232,569